Jump to start of content

Breadcrumb trail:

Critical Care Medicine Approval Committees

Longitudinal Knowledge Assessment

Expand All | Collapse All

Margaret Pisani, MD, Chair

Dr. Pisani is an Associate Professor of Medicine at Yale University and Fellowship Program Director in the Pulmonary, Critical Care and Sleep Medicine Section. She is board certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine.

Dr. Pisani is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, she has served in various capacities on peer review groups, grant study sections and advisory boards such as CHEST Foundation, American College of Chest Physicians, National Institutes of Health Clinical and Translational Science Award and Connecticut Thoracic Society. She serves as reviewer for seven prestigious science journals and on Heart & Lung: The Journal of Acute and Critical Care's editorial board. She is a longstanding member of the Association of Subspecialty Professors, Chest Foundation Community Service, American College of Chest Physicians, American Thoracic Society and Society for Critical Care Medicine.

Dr. Pisani's leadership roles at Yale have included service on the Graduate Medical Education Committee, Geriatric Section Chief Search Committee, Internship Selection Committee, Internal Medicine Research Advisory Panel and Physician Scientist Recruitment Committee. She has chaired the Pulmonary Fellowship curriculum, research advisory and milestone committees, and is a longstanding member of the Medical Intensive Care Unit committee.

With over 46 peer-reviewed original publications in prestigious scientific journals, Dr. Pisani's research focuses on improving care and outcomes of older critically ill patients, with a current focus on sleep in critically ill patients, its impact on delirium and other patient outcomes.

Dr. Pisani received her physics degree from Iona College, a master's degree in biomedical engineering from New Jersey Institute of Technology, her medical degree from Temple University and master's degree in public health in chronic disease epidemiology at Yale University.

As of August 2022, Dr. Pisani reported the following external relationships:

Dr. Pisani serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Women in Pulmonary Advisory Board and Diversity, Equity & Inclusion Advisory Committee, Vice Chair of Council of Networks, without compensation.

Thomas P. Bleck, MD, MCCM

Dr. Bleck is Professor of Neurology at the Northwestern University Feinberg School of Medicine, where he directs the Neurocritical Care Fellowship. In 2018 he retired as Professor Emeritus of Neurological Sciences, Neurosurgery, Internal Medicine, and Anesthesiology at Rush Medical College, where he was a neurointensivist and the Director of Clinical Neurophysiology. From 2009 – 2015, he was the Associate Chief Medical Officer for Critical Care. He was the Founding President of the Neurocritical Care Society. From 1992 – 2015, he was the Neuroscience Section editor of Critical Care Medicine; from 2015 – 2021, was an associate editor; and is currently a senior editor. He also serves on the editorial boards of Annals of Intensive Care and Current Opinion in Critical Care. For 12 years, he was a member of the Council of the Society of Critical Care Medicine (SCCM). In 2015, the American College of Critical Care Medicine and the SCCM elected him a Master of Critical Care Medicine; there are 87 masters out of 18,000 members. He previously served on the board of the American Board of Clinical Neurophysiology, the writing committee of the American Board of Psychiatry and Neurology, the American Board of Internal Medicine (ABIM) subspecialty exam committee in critical care medicine, and the accreditation committee for neurocritical care of the American Board of Neurological Surgery (ABPN). In 2018, he was appointed to the ABPN Neurocritical Care Examination Development Committee. He is an elected fellow of 11 professional societies. In 2017, he was elected to the Board of Directors of the American Neurological Association. In 2018, he received the SCCM lifetime achievement award. In 2019, he delivered the Anthony Marmarou Memorial Lecture for the American Association of Neurological Surgeons. In 2021 he was inducted into the Feinberg Academy of Medical Educators of Northwestern University. He currently serves on the ABIM’s Critical Care Medicine Approval Committee.

From 1990 – 2006, he directed the Neuroscience Intensive Care Unit at the University of Virginia as the Louise Nerancy Eminent Scholar in Neurology. From 2006 – 2009, he chaired the Neurology Department of Evanston Northwestern Healthcare, and was Professor and Vice-Chair for Academic Programs at Northwestern, where he also directed the Division of Neurocritical Care. In 2009, he moved to Rush as the Associate Chief Medical Officer for Critical Care. In 2017, he was the interim neurology residency program director. His research interests include subarachnoid hemorrhage, in-tracerebral hemorrhage, head injury, status epilepticus, infections, neuromuscular respiratory failure, and the ICU management of the organ donor. He has published 223 papers, 138 abstracts, 22 editorials, and 205 books and book chapters; and conducted more than 580 national and international visiting appointments and lectureships in 30 countries.

Dr. Bleck is board certified by the American Board of Internal Medicine in internal medicine, with subspecialty certification in critical care medicine; the American Board of Psychiatry and Neurology in neurology, with subspecialty certifications in epilepsy and neurocritical care; the American Board of Clinical Neurophysiology; and in neurocritical care by both the United Council on Neurological Subspecialties and the Committee on Advanced Surgical Training of the Society of Neurological Surgeons and the American Board of Neurological Surgeons.

Dr. Bleck earned his bachelor’s degree from Northwestern University and his medical degree from Rush Medical College. He completed his internal medicine and neurological sciences residencies and his electroencephalography and epilepsy fellowship at Rush Presbyterian Saint Luke’s Medical Center.

As of July 2022, Dr. Bleck reported the following external relationships:

Service on data and safety monitoring boards for the following company, with honoraria:

  • Marinus Sage

Work as an author or editor for the following company, with compensation as listed:

  • The Society of Critical Care Medicine, Critical Care Medicine, Senior Editor

Dr. Bleck serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The Neurocritical Care Society, ex officio Board of Directors, without compensation

Dr. Bleck also reported being on a steering committee for the National Institute of Neurological Disorders and Stroke/National Heart, Lung, and Blood Institute (NINDS/NHLBI) study of ketamine in status epilepticus.

Gina Iacovella, MD

Gina M. Iacovella, MDDr. Iacovella is an intensivist for the Intensive Care Consortium at Brandon Regional Hospital in Brandon, Florida, which is an affiliate teaching hospital of the University of South Florida. She is board certified in Internal Medicine, Nephrology and Critical Care Medicine.

Previously, Dr. Iacovella worked at Lakeland Regional Hospital in Lakeland, Florida as an intensivist caring for a large underserved population at a Level II Trauma Center.

Dr. Iacovella is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, she is an active member of both the American Society of Nephrology and the Society of Critical Care Medicine.

Dr. Iacovella received both her undergraduate degree in biology and master’s degree in bio-analytical chemistry from the University of South Carolina in Columbia, South Carolina. She earned her medical degree at the Medical University of South Carolina in Charleston, South Carolina. Dr. Iacovella completed internal medicine residency at Cedars-Sinai Medical Center in Los Angeles, California, a fellowship in nephrology at Yale University in New Haven, Connecticut and a fellowship in critical care medicine at Mayo Clinic in Rochester, Minnesota.

As of August 2022, Dr. Iacovella reported no ongoing external relationships.

John McArdle, MD

John R. McArdle, MDDr. McArdle, who is board certified in internal medicine, pulmonary disease, and critical care medicine, is employed in the full-time clinical practice of pulmonary and critical care medicine for Starling Physicians, PC. He is also Chief of the Pulmonary Division at Hartford Hospital and he is co-Director of the Marie and Raymond Beauregard Central Connecticut Adult Cystic Fibrosis Program.

Previously, Dr. McArdle was an Associate Professor of Medicine at Yale University School of Medicine in the section of Pulmonary and Critical Care Medicine. He directed the Yale Adult Cystic Fibrosis Program, served as Medical Director of the medical intensive care unit, and was Clerkship Director for the Yale University School of Medicine Internal Medicine Clerkship.

He is a former President of the Connecticut Pulmonary Section of the American Lung Association, and is a member of the American Board of Internal Medicine's Critical Care Examination Committee. Dr. McArdle received the Yale Department of Internal Medicine Faculty Achievement Award for Outstanding Clinical Care in 2008. He was twice awarded the attending teacher the year by the Yale Internal Medicine Housestaff, and receive the Aldo Bellucci Teaching Award from the University Connecticut internal medicine residency program in 2012. He was awarded the John K Springer Humanitarian Award by Hartford Hospital in 2017. He served on the Cystic Fibrosis Lung Transplant Referral Guidelines Committee in 2018-2019.

Dr. McArdle received a degree in economics and preprofessional studies from the University of Notre Dame and his medical degree from the State University of New York at Buffalo School of Medicine and Biomedical Sciences. He completed his internal medicine residency, chief residency, and pulmonary and critical care fellowship training at the Yale University School of Medicine.

As of September 2022 Dr. McArdle reported no ongoing external relationships:

Jennifer Wilson, MD

Dr. Wilson is a Clinical Associate Professor of Emergency Medicine and Critical Care at Stanford University School of Medicine, where she attends in the medical-surgical ICU and leads the Stanford Emergency Critical Care Program. After completing her training, she joined the emergency medicine and critical care faculty at University of California San Francisco (UCSF). In 2017 Dr. Wilson joined the faculty at Stanford to help start the Interdisciplinary Emergency Critical Care Program, which focuses on improving the care of critically ill patients in the Emergency Department (ED). In addition to her clinical practice, Dr. Wilson is a clinical researcher focused on transitions of care between the ED and ICU, and early interventions for acute respiratory distress syndrome and sepsis.

Dr. Wilson received her master’s degree from the University of California Berkeley. She earned her medical degree and completed her residency in Emergency Medicine at UCSF/San Francisco General and stayed at UCSF for critical care fellowship as part of an ABIM training program.

View my board certification status via ABMS Website

As of May 2023, Dr. Wilson reported no ongoing external relationships.

Traditional, 10-Year MOC Exam

Expand All | Collapse All

Christopher F. Barnett, MD, Chair

Christopher F. Barnett, MD

Dr. Barnett is a Professor of Medicine and Chief of the Section of Critical Care Cardiology at the University of California, San Francisco (UCSF). He is board certified in Critical Care Medicine, Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology. Dr. Barnett previously served as Director of the Pulmonary Hypertension Program and Director of the Medical Cardiovascular Intensive Care Unit at MedStar Heart & Vascular Institute.

Dr. Barnett specializes in the care of patients with pulmonary hypertension as well as patients who are critically ill with cardiovascular disease. In his pulmonary hypertension practice, he manages patients with advanced therapies including parenteral treatments. In the cardiac intensive care unit, he leads a multidisciplinary team that provides optimal, collaborative care to patients with severe cardiovascular disease as well as to patients before and after advanced, special cardiovascular procedures. He works closely and collaboratively with referring providers and other specialist physicians, including transplant cardiologists and the palliative care team at MedStar Washington Hospital Center.

Dr. Barnett is a member of the American Board of Internal Medicine Critical Care Medicine Traditional, 10-Year MOC Exam Approval Committee, the International Society for Heart & Lung Transplantation, the American College of Cardiology and the Pulmonary Hypertension Association.

Dr. Barnett received his medical degree and his master's degree in public health from Northwestern University. He completed his internal medicine residency at Northwestern Memorial Hospital in Chicago. He then completed a clinical and research fellowship in critical care medicine at the National Institutes of Health, followed by a fellowship in cardiovascular disease at the University of California, San Diego.

As of May 2023, Dr. Barnett reported the following external relationships:

Funding for clinical trial expenses and staff, paid to UCSF, from the following company:

  • Merck, for pulmonary arterial hypertension studies

Dr. Barnett serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American College of Cardiology, Session Planning Committee, without compensation
  • The American Heart Association, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, 3CPR Leadership Committee, Member-at-Large, without compensation

Alain Broccard, MD

Dr. Broccard currently serves as the Medical Director for St. Vincent Seton Specialty Hospital located in Indianapolis. He is board certified Internal Medicine, Critical Care Medicine, Pulmonary Disease and Sleep Medicine. Previously, Dr. Broccard was Chairman of the Pulmonary and Critical Care Department at Vassar Brothers Medical Center in Poughkeepsie, New York. Prior to this appointment, he served as Professor of Medicine at the University of Minnesota where he developed and led the Critical Care and Respiratory Therapy Services at Fairview Southdale Hospital in Edina, Minnesota. Before this latter position, Dr. Broccard was the MICU Medical Director and subsequently Critical Care Section Head for Regions Hospital in St. Paul, Minnesota.

Dr. Broccard is a member of the American Board of Internal Medicine Critical Care Medicine Board Exam Committee. Additionally, he has served on various committees of the American Thoracic Society. He has received multiple awards from the Swiss Intensive Care Society and from the University of Minnesota Medical School. Dr. Broccard was a reviewer for major United States and European critical care journals and was on the editorial board of the American Journal of Respiratory and Critical Care Medicine. He has extensively published on ventilator-induced lung injury and has been an invited lecturer at major international critical care society meetings and institutions both in the United States and abroad.

Dr. Broccard received his medical degree from the University of Geneva Medical School, Switzerland. He completed his house staff training at Geneva University Hospital and further critical care training at Lausanne University Hospital, Switzerland. He subsequently completed pulmonary and critical care fellowships at the University of Minnesota and at the Mayo Clinic in Rochester, Minnesota.

As of September 2022, Dr. Broccard reported the following external relationships:

Service on data and safety monitoring boards for the following organization, without compensation:

  • The National Institutes of Health

Cherylee W. J. Chang, MD, FCCM, FACP, FNCS

Cherylee W. J. Chang, MD

Dr. Chang is a member of the Council of the Society of Critical Care Medicine in the designated seat for the Neurosciences and has served as an Associate Editor for one of the society’s official journals, Critical Care Medicine. She is member of the American Board of Internal Medicine’s Critical Care Medicine Approval Committee and the American Board of Psychiatry and Neurology’s Neurocritical Care Examination Committee. She was also the third president of the Neurocritical Care Society from 2007 to 2009, and served in a leadership role in creating certification of individuals and accreditation of fellowship training programs in neurological critical care through her work with the United Council of Neurological Specialties as the chair of the Neurointensive Care Examination Committee. She serves as a liaison to the Neurocritical Care Accreditation Committee of the Committee on Advanced Subspecialty Training for the Society of Neurological Surgeons. Dr. Chang is also a member of the Board of Directors of the Rehabilitation Hospital of the Pacific and was a founding member of the taskforce for Providers for Life-Sustaining Treatment (POLST) for the State of Hawaii.

Dr. Chang was the Medical Director of the Neuroscience Institute and Neurocritical Care at the Queen’s Medical Center (QMC) in Honolulu, Hawaii, founded QMC’s TJC-certified Stroke Center in 1997 and directed it until 2017. She relocated to Durham, North Carolina, in 2020 to become the first Division Chief of Neurocritical Care at Duke University as a Professor of Neurology.

Dr. Chang received her bachelor’s degree in Biological Sciences with Honors and Distinction from Stanford University and her medical degree at the University of California, San Diego. She completed residencies in neurology and internal medicine at Stanford University Medical Center and UC San Diego, respectively, and joint fellowships in critical care medicine and neurocritical care at the University of Virginia. She is board certified in neurology, critical care medicine and neurocritical care. 

As of May 2023, Dr. Chang reported the following external relationships:

Dr. Chang serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  •  The American Board of Psychiatry and Neurology, American Board of Psychiatry and Neurology Neurocritical Care Writing Committee, representing the American Board of Internal Medicine, receiving reimbursement for travel expenses.
  • Critical Care Medicine, Associate Editor, receiving an annual stipend.
  • The Society of Critical Care Medicine, Treasurer; Executive Committee of the Council, Treasurer, receiving reimbursement for travel expenses.
  • The Neurocritical Care Society, Past President, for attending some Board meetings and strategic planning meetings, and giving lectures at the annual meeting, receiving reimbursement for travel expenses.
  • Rehabilitation Hospital of the Pacific, Board of Directors, Member; Board Quality Improvement Committee, Chair, without compensation.

Lillian L. Emlet, MD, MS

Lillian EmletDr. Emlet is Clinical Associate Professor of Critical Care Medicine (CCM) & Emergency Medicine (EM) and Associate Program Director of the Internal Medicine-Critical Care Medicine Fellowship of the Multidisciplinary Critical Care Training Program at the University of Pittsburgh Medical Center. Dr. Emlet has served since 2010 as the Associate Program Director of the Internal Medicine-Critical Care Medicine fellowship of the Multidisciplinary Critical Care Training Program (MCCTP) at the VA Pittsburgh Healthcare System, and directs core modules in airway management, rapid response team crisis training, and teaches via simulation skills in team leadership, palliative end-of-life communication, and difficult airway management. She is board certified in Emergency Medicine, Internal Medicine-Critical Care Medicine, and Neurocritical Care Medicine.

She has served on national committees through the Society for Simulation in Healthcare (fostering interprofessional faculty and simulation development), American College of Emergency Physicians (fostering mentorship of dually trained EM-CCM physicians), and Society of Critical Care Medicine (fostering multispecialty critical care delivery).

She created the Virtual Mentor program in 2009, which is a national mentoring program for students and residents in EM who seek to pursue a career in EM and CCM, currently housed at the Emergency Medicine Resident Association (EMRA) Critical Care Division. She is a VitalTalk trained educator (www.vitaltalk.org), and has created EMTalk, which teaches primary palliative communication skills to EM residents and faculty nationally.

Dr. Emlet received her master’s degree in pharmacology and medical degree at Jefferson Medical College. She trained in emergency medicine at Geisinger Medical Center and critical care medicine at the University of Pittsburgh Medical Center, where she also completed a master’s of science in medical education at the University of Pittsburgh.

View my board certification status via ABMS Website

As of September 2022, Dr. Emlet reported the following external relationships:

Dr. Emlet receives funding from the following organizations, receiving grant funding or compensation as listed:

  • Veteran's Research Foundation, receiving funding for expenses annually for projects that benefit the improvement of safety, education and care delivery at VA Pittsburgh Healthcare System
  • VitalTalk, receiving honoraria for teaching

Ryan Maves, MD, FCCM, FCCP, FIDSA

Dr. Maves is a Professor of Medicine and Anesthesiology at Wake Forest University School of Medicine where he serves as an attending physician in infectious diseases and critical care medicine. Previously, he served at U.S. Naval Medical Research Unit No.6 in Lima, Peru, leading studies in antimicrobial drug resistance and vaccine development and as Division Head in Infectious Diseases for the Naval Medical Center San Diego. Dr. Maves was previously deployed as Director of Medical Services to the NATO Role III Multinational Medical Unit at Kandahar International Airport in Afghanistan. He later served as Vice Chair of Medicine and Infectious Diseases Fellowship Program Director while leading multicenter studies in COVID-19 therapeutics and epidemiology. He retired from the United States Navy with the rank of Captain in 2021 after 22 years of active-duty service, and joined the faculty at Wake Forest.

Dr. Maves is board certified in Internal Medicine, Infectious Diseases and Critical Care Medicine. He maintains active clinical practices in transplant infectious diseases in addition to medical, surgical, cardiovascular and neurologic critical care. His research interests include the epidemiology and treatment of severe viral diseases and hospital preparedness for public health emergencies.

A graduate of the University of Washington School of Medicine, Dr. Maves completed his internal medicine residency and fellowships in infectious diseases and critical care at the Naval Medical Center in San Diego.

As of May 2023, Dr. Maves reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Wake Forest University, from the following companies:

  • Sound Pharmaceuticals, receiving clinical trial support for a COVID-19 investigational agent.
  • AiCuris, for a clinical trial of investigational agent for resistant herpes simplex viral infections.
  • Geovax, for a clinical trial of an investigational COVID-19 vaccine in bone marrow transplant recipients.

Service on data and safety monitoring boards for the following companies, with honoraria:

  • LumaBridge, for service as a medical monitor for a clinical trial of sepsis care.

Service on a research-related expert panel or advisory board for the following companies, with honoraria:

  • Shionogi, for service on a scientific advisory panel.

Dr. Maves serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Chair, Disaster Response and Global Health Section, Member of Scientific Programming Committee, receiving reimbursement for travel expenses.
  • Society of Critical Care Medicine, Chair, FCCS: Crisis Management Committee, Member, Congress Program Committee, receiving reimbursement for travel expenses.

Naomi O'Grady, MD

Dr. O’Grady is the Chief of the Internal Medicine Service and an attending physician in the Clinical Center's Critical Care Medicine Department (CCMD). She has previously served as the Medical Director of the Clinical Center's Procedures, Vascular Access and Conscious Sedation Services and as the CCMD's Medical Director of Patient Safety and Quality.

Her research focuses on strategies to reduce the incidence of antimicrobial resistant pathogens in the ICU, and catheter-related blood stream infections.

Dr. O'Grady is a past Chair of the American Board of Internal Medicine Specialty Board for Critical Care Medicine and has served on the ABIM Council and the Board of Directors. She is a fellow of the Infectious Diseases Society of America and of the American College of Critical Care Medicine.

She obtained her undergraduate degree from University of Michigan and her medical degree at The Ohio State University, where she also completed her internship and residency. She then completed fellowships with National Institutes of Health (NIH) in Critical Care Medicine and Johns Hopkins University in Infectious Diseases before joining the NIH attending staff in 1999.

As of July 2022, Dr. O’Grady reported no ongoing external relationships.